LLY

824.65

+1.39%↑

UNH

499.07

+2.21%↑

JNJ

163.02

+0.06%↑

NVO

80.29

+3.98%↑

ABBV

214.79

+1.37%↑

LLY

824.65

+1.39%↑

UNH

499.07

+2.21%↑

JNJ

163.02

+0.06%↑

NVO

80.29

+3.98%↑

ABBV

214.79

+1.37%↑

LLY

824.65

+1.39%↑

UNH

499.07

+2.21%↑

JNJ

163.02

+0.06%↑

NVO

80.29

+3.98%↑

ABBV

214.79

+1.37%↑

LLY

824.65

+1.39%↑

UNH

499.07

+2.21%↑

JNJ

163.02

+0.06%↑

NVO

80.29

+3.98%↑

ABBV

214.79

+1.37%↑

LLY

824.65

+1.39%↑

UNH

499.07

+2.21%↑

JNJ

163.02

+0.06%↑

NVO

80.29

+3.98%↑

ABBV

214.79

+1.37%↑

Search

CareDx Inc

Closed

Sector Healthcare

19.21 1.75

Overview

Share price change

24h

Current

Min

18.44

Max

19.32

Key metrics

By Trading Economics

Income

85M

78M

Sales

3.7M

87M

P/E

Sector Avg

20.326

72.392

EPS

0.18

Profit margin

90.103

Employees

644

EBITDA

90M

84M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+47.25% upside

Dividends

By Dow Jones

Next Earnings

8 May 2025

Market Stats

By TradingEconomics

Market Cap

-97M

1B

Previous open

17.46

Previous close

19.21

Technical Score

By Trading Central

Confidence

Bearish Evidence

CareDx Inc Chart

Past performance is not a reliable indicator of future results.

Related News

17 Mar 2025, 23:30 UTC

Hot Stocks

Stocks to Watch: Harrow, Bakkt Holdings, Alphabet

17 Mar 2025, 23:59 UTC

Market Talk

More Time Needed to Form View on NAB's New Hire -- Market Talk

17 Mar 2025, 23:43 UTC

Market Talk

Nikkei May Rise as Fears About U.S. Tariffs Recede -- Market Talk

17 Mar 2025, 23:43 UTC

Earnings

Smoore International: New Products Expected to Present More Opportunities for Rev Growth >6969.HK

17 Mar 2025, 23:43 UTC

Earnings

Smoore International: Will Introduce More Innovative Products to Meet Evolving Consumer Demands >6969.HK

17 Mar 2025, 23:42 UTC

Earnings

Smoore International: Rev Mainly From Corporate Client Oriented Business, Self-Branded Business >6969.HK

17 Mar 2025, 23:39 UTC

Earnings

Smoore International 2024 Net CNY1.30B Vs. Net CNY1.645B >6969.HK

17 Mar 2025, 23:39 UTC

Earnings

Smoore International 2024 Rev CNY11.80B Vs. CNY11.20B >6969.HK

17 Mar 2025, 23:17 UTC

Market Talk

BlackRock Jittery About Outlook for US Bond Yields -- Market Talk

17 Mar 2025, 23:01 UTC

Market Talk

Williams Cos. Seen as Company With Most 'Shots on Goal' in Natural Gas Space -- Market Talk

17 Mar 2025, 23:00 UTC

Top News

Santander Pushes to Expand U.S. Operations by Utilizing Verizon Customer Base -- WSJ

17 Mar 2025, 22:29 UTC

Earnings

WuXi AppTec: Impairment Losses, Higher Finance Costs Among Factors Affecting Net>603259.SH

17 Mar 2025, 22:29 UTC

Earnings

WuXi AppTec Board Announces Special Dividend of CNY3.50 For Every 10 Shares Held >603259.SH

17 Mar 2025, 22:29 UTC

Earnings

WuXi AppTec 2024 Net CNY9.35B Vs. Net CNY10.69B >603259.SH

17 Mar 2025, 22:29 UTC

Earnings

WuXi AppTec 2024 Rev CNY39.24B Vs. CNY40.34B >603259.SH

17 Mar 2025, 22:24 UTC

Top News
Acquisitions, Mergers, Takeovers

Google in Fresh Talks to Buy Cybersecurity Startup Wiz for $30 Billion -- 2nd Update

17 Mar 2025, 22:16 UTC

Acquisitions, Mergers, Takeovers

Microsoft: Expresses No Opinion and Is Neutral on TRC's Offer >MSFT

17 Mar 2025, 22:15 UTC

Acquisitions, Mergers, Takeovers

Microsoft: Not Affiliated With TRC, Doesn't Endorse Offer Documentation or Offer Itself >MSFT

17 Mar 2025, 22:14 UTC

Acquisitions, Mergers, Takeovers

Microsoft Responds to TRC Capital's 'Mini-Tender' Offer

17 Mar 2025, 21:19 UTC

Top News

Stocks Haven't Traded at These Levels Since September -- Update

17 Mar 2025, 21:12 UTC

Acquisitions, Mergers, Takeovers

Google Restarts Acquisition Talks With Cybersecurity Firm Wiz -- IBD

17 Mar 2025, 20:54 UTC

Top News
Acquisitions, Mergers, Takeovers

Google in Fresh Talks to Buy Cybersecurity Startup Wiz for $30 Billion -- Update

17 Mar 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

17 Mar 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

17 Mar 2025, 20:26 UTC

Market Talk

Gold Settles at Record $3,000/oz -- Market Talk

17 Mar 2025, 20:24 UTC

Top News

Dow Rises Nearly 1%, Building on Friday's Gains -- WSJ

17 Mar 2025, 20:15 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Global Commodities Roundup: Market Talk

17 Mar 2025, 20:09 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Pepsi's Poppi Deal Attractive, With International Sales Potential -- Market Talk

17 Mar 2025, 20:03 UTC

Top News
Acquisitions, Mergers, Takeovers

Alphabet Back in Deal Talks for Cybersecurity Startup Wiz -- WSJ

17 Mar 2025, 19:25 UTC

Market Talk

Mark Carney's Liberals Pull Ahead in Latest Canada Polling -- Market Talk

Peer Comparison

Price change

CareDx Inc Forecast

Price Target

By TipRanks

47.25% upside

12 Months Forecast

Average 27.83 USD  47.25%

High 35 USD

Low 23.5 USD

Based on 4 Wall Street analysts offering 12 month price targets forCareDx Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

4 ratings

2

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

18.965 / 20.425Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.